TrialNature medicine2026
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.
Zhi Peng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
TrialNature medicine2026
Zhi Peng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.